Search

for
Search:

GlossaryDocetaxel

chemotherapy drug that inhibits cancer cell division

Docetaxel, also known by the brand name Taxotere, is a chemotherapy medication used to treat various types of cancer, including breast, lung, prostate, and stomach cancers. It works by inhibiting cell division, which helps to stop the growth and spread of cancer cells.

Related Terms

Learn

0 / 0 results

— no results

Research

5 / 320 results

research Skin Toxicity of Anti-Cancer Therapy

19 citations, October 2008 in “Journal der Deutschen Dermatologischen Gesellschaft”

Anti-cancer treatments can cause reversible hair loss, skin sensitivity, pigmentation changes, nail damage, and skin reactions, with a need for more research on managing these side effects.

research Systematic Review of the Risk of Permanent Alopecia with Docetaxel Treatment for Breast Cancer

January 2016 in “Journal of clinical case reports”

Docetaxel treatment for breast cancer can cause permanent hair loss.

research Permanent Chemotherapy-Induced Alopecia in Early Breast Cancer Patients After (Neo)Adjuvant Chemotherapy: Long-Term Follow-Up

2 citations, December 2013 in “Cancer Research”

Some early breast cancer patients have long-term hair loss after chemotherapy, especially older and postmenopausal women.

research Irreversible And Severe Alopecia Following Docetaxel Or Paclitaxel Cytotoxic Therapy For Breast Cancer

61 citations, April 2009 in “British journal of dermatology/British journal of dermatology, Supplement”

Docetaxel and paclitaxel for breast cancer can cause permanent, severe hair loss.

research Multiple Drugs

June 2017 in “Reactions Weekly”

Some breast cancer treatments caused long-term hair loss in women, similar to a condition called alopecia areata.

View more "docetaxel" in research →

Community Join

0 / 0 results

— no results